Crystal Growth & Design
Article
nicotinic acid) on platelet function and fibrinolytic activity in vitro.
Thromb. Res. 1975, 6, 9.
(3) Arkel, Y. S.; Schrogie, J. J.; Williams, R. Effect of clonixin and
aspirin on platelet aggregation in human volunteers. J. Clin.
Pharmacol. 1976, 16, 30.
(4) Morse, E. E. Effects of drugs on platelet function. Ann. Clin. Lab.
Sci. 1977, 7, 68.
(5) Krymchantowski, A. V.; Carneiro, H.; Barbosa, J.; Jevoux, C.
Lysine clonixinate versus dipyrone (metamizole) for the acute
treatment of severe migraine attacks: a single-blind, randomized
study. Arq. Neuro-Psiquiatr. 2008, 66, 216.
Compounds 1, 2, and 3 were found to be polymorphic, as two
forms were discovered for each, while for compound 4, only
one form was identified. Similar to CLX, the molecules in their
crystals are connected either by the acid−acid dimer
homosynthon or the acid−pyridine heterosynthon, depending
on the dihedral angle between the two aromatic rings.
Isostructurality was observed between 2-I, 3-I and form I of
CLX and between 2-II, 3-II and form IV of CLX, likely due to
the similar electronegativity and not significant size difference.
4 is isostructural to 1-I, but not to the other crystals, possibly
because of the size similarity between F and H and
electronegativity dissimilarity between F/H and Cl, Br, and I.
Phase behaviors of the polymorphic systems were studied by
DSC, which showed phase transitions between the different
forms in each system. Conformational energy, hydrogen-bond
strength calculations, and conformation scans suggested both
conformational flexibility and the possibility of multiple
hydrogen-bonding motifs lead to the polymorphism of the
compounds and suggest additional forms might be found for
each compound. Lattice energy evaluation and Hirshfeld
analysis further provided insight on the relative stability of the
polymorphs of each system and contributions to the stability of
each form. The lack of polymorphs of compound 4 deserves
further investigation.
(6) Nangia, A. Conformational polymorphism in organic crystals.
Acc. Chem. Res. 2008, 41, 595.
(7) Cruzcabeza, A. J.; Bernstein, J. Conformational polymorphism.
Chem. Rev. 2014, 114, 2170−2191.
(8) Takasuka, M.; Nakai, H.; Shiro, M. Infrared spectral and X-Ray
studies of polymorphic forms of 2-(2-methyl-3-chloroanilino)-
nicotinic acid. J. Chem. Soc., Perkin Trans. 2 1982, 2, 1061.
(9) Long, S.; Mao, T. F.; Chen, P.; Liu, M.; Parkin, S.; Zhang, M.; Li,
T.; Zhou, P.; Yu, F. Strong hydrogen bond leads to a fifth crystalline
form and polymorphism of clonixin. ChemistrySelect 2017, 2, 4942.
(10) Long, S.; Parkin, S.; Siegler, M. A.; Cammers, A.; Li, T.
Polymorphism and phase behaviors of 2-(Phenylamino)nicotinic acid.
Cryst. Growth Des. 2008, 8, 4006.
(11) Long, S.; Parkin, S.; Siegler, A.; Brock, C.; Cammers, A.; Li, T.
Polymorphism of an organic system effected by the directionality of
hydrogen-bonding chains. Cryst. Growth Des. 2008, 8, 3137.
(12) Long, S.; Li, T. Controlled Formation of the Acid-Pyridine
Heterosynthon over the Acid-Acid Homosynthon in 2-Anilinonico-
tinic Acids. Cryst. Growth Des. 2009, 9, 4993.
(13) Long, S.; Li, T. Enforcing molecule’s π-conjugation and
consequent formation of the acid-acid homosynthon over the acid-
pyridine heterosynthon in 2-anilinonicotinic acids. Cryst. Growth Des.
2010, 10, 2465.
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge on the
■
S
Synthesis of CLX analogues; IR and Raman spectra
(14) Chen, P.; Zhang, Z.; Parkin, S.; Zhou, P.; Cheng, K.; Li, C.; Yu,
F.; Long, S. Preferred formation of the carboxylic acid−pyridine
heterosynthon in 2-anilinonicotinic acids. RSC Adv. 2016, 6, 81101.
(15) Long, S.; Zhou, P.; Parkin, S.; Li, T. From competition to
commensuration by two major hydrogen-bonding motifs. Cryst.
Growth Des. 2014, 14, 27.
(16) Mattei, A.; Li, T. Interplay between molecular conformation
and intermolecular interactions in conformational polymorphism: A
molecular perspective from electronic calculations of tolfenamic acid.
Int. J. Pharm. 2011, 418, 179.
(17) Kermack, W. O.; Weatherhead, A. P. Some anilinopyridine
derivatives. J. Chem. Soc. 1942, 726.
(18) Ting, P. C.; Kaminski, J. J.; Sherlock, M. H.; Tom, W. C.; Lee,
J. F.; Bryant, R. W.; Watnick, A. S.; McPhail, A. T. Substituted 1,3-
dihydro-2H-pyrrolo[2,3-b]pyridin-2-ones as potential antiinflamma-
tory agents. J. Med. Chem. 1990, 33, 2697.
Accession Codes
tallographic data for this paper. These data can be obtained
Cambridge Crystallographic Data Centre, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
AUTHOR INFORMATION
Corresponding Authors
■
ORCID
(19) Chen, P.; Jin, Y.; Zhou, P.; Parkin, S.; Zhang, Z.; Long, S. Solid-
state characterization of 2-[(2,6-dichlorophenyl)amino]-benzalde-
hyde: an experimental and theoretical investigation. J. Chin. Chem.
Soc. 2017, 64, 531.
(20) Nonius Collect; Nonius BV: Delft, the Netherlands, 2002.
(21) Sheldrick, G. M. A short history of SHELX. Acta Crystallogr.,
Sect. A: Found. Crystallogr. 2008, 64, 112.
Notes
The authors declare no competing financial interest.
(22) Sheldrick, G. M. Crystal structure refinement with SHELXL.
Acta Crystallogr., Sect. C: Struct. Chem. 2015, 71, 3.
(23) Hirshfeld, F. L. Bonded-atom fragments for describing
molecular charge densities. Theor. Chim. Acta 1977, 44, 129.
(24) Spackman, M. A.; Jayatilaka, D. Hirshfeld surface analysis.
CrystEngComm 2009, 11, 19.
(25) Becke, A. D. Density-functional thermochemistry. III. The role
of exact exchange. J. Chem. Phys. 1993, 98, 5648.
(26) Krishnan, R.; Binkley, J. S.; Seeger, R.; Pople, J. A. Self-
consistent molecular orbital methods. XX. A basis set for correlated
wave functions. J. Chem. Phys. 1980, 72, 650.
ACKNOWLEDGMENTS
■
S.L. thanks Natural Science Foundation of Hubei Province for
financial support (2014CFB787). T.L. is grateful to NSF for
supporting the work (DMR1006364).
REFERENCES
■
(1) Sherlock, M. H.; Sperber, N. Antiinflammatory 2-Anilinonico-
tinic acids. Br. Pat. GB 1147701, 1969.
(2) Widmer, K.; Reed, R. C.; Freireich, E. J. The influence of a new
analgetic-antiphlogistic compound (2-(2-methyl-3′chloro)-anilino-
H
Cryst. Growth Des. XXXX, XXX, XXX−XXX